Madrigal Pharmaceuticals IncChange company Symbol lookupSelect an option...MDGL Madrigal Pharmaceuticals IncKEY KeyCorpHGKGY Power Assets Holdings LtdICPT Intercept Pharmaceuticals IncTTWO Take-Two Interactive Software IncTOPS Top Ships IncBOLT Bolt Biotherapeutics IncACET Adicet Bio IncVCNX Vaccinex IncDYNT Dynatronics CorpGo
Change company Symbol lookup
Select an option...
MDGL Madrigal Pharmaceuticals Inc
KEY KeyCorp
HGKGY Power Assets Holdings Ltd
ICPT Intercept Pharmaceuticals Inc
TTWO Take-Two Interactive Software Inc
TOPS Top Ships Inc
BOLT Bolt Biotherapeutics Inc
ACET Adicet Bio Inc
VCNX Vaccinex Inc
DYNT Dynatronics Corp
Health Care : Biotechnology | Small Cap Value
Company profileMadrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a proprietary, liver-directed, selective thyroid hormone receptor-B (THR-B), agonist being developed as a once-daily oral pill for the treatment of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). NASH is a liver disease that affects people with metabolic diseases, such as obesity and diabetes and non-alcoholic fatty liver disease (NAFLD).
|
|
|
|
| |
| Latest Earnings Met Consensus (Q2 ending 06/2023) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced August 8, 2023 | -$4.69 | Q2 Estimate range of 10 analysts | -$5.08 to -$4.22 | Q3 Earnings will announce | (Unconfirmed) November 1, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
MDGL's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.